CIK 0001018735 · Accelerated filer
NYMOX PHARMACEUTICAL CORP
Sign in to watch- Ticker
- NYMXF
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Entity type
- other
- Phone
- 1-800-936-9669
- Business address
- 9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- NT 20-F Other Notification of Inability to Timely File
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
Page 1 of 21 · 408 filings